IDENTIV INC (INVE) Forecast, Price Target & Analyst Ratings

NASDAQ:INVEUS45170X2053

Current stock price

3.67 USD
-0.12 (-3.17%)
At close:
3.5863 USD
-0.08 (-2.28%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IDENTIV INC (INVE).

Forecast Snapshot

Consensus Price Target

Price Target
$5.44
+ 48.23% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.16
Revenue Estimate
7.055M

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.44
Upside
+ 48.23%
From current price of $3.67 to mean target of $5.44, Based on 9 analyst forecasts
Low
$5.05
Median
$5.10
High
$6.30

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for INVE. The average price target is 5.44 USD. This implies a price increase of 48.23% is expected in the next year compared to the current price of 3.67.

Analyst Ratings & History

Current Analyst Ratings

INVE Current Analyst RatingINVE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

INVE Historical Analyst RatingsINVE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
INVE was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about INVE.
In the previous month the buy percentage consensus was at a similar level.
INVE was analyzed by 9 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-08-08B. Riley SecuritiesMaintains Buy -> Buy
2025-05-08Lake StreetMaintains Buy -> Buy
2025-03-06Lake StreetMaintains Buy -> Buy
2024-08-09B. Riley SecuritiesMaintains Buy -> Buy
2024-08-09Craig-HallumMaintains Buy -> Buy
2024-05-09Craig-HallumMaintains Buy -> Buy
2024-03-13B. Riley SecuritiesMaintains Buy -> Buy
2023-06-26B. Riley SecuritiesUpgrade Neutral -> Buy
2022-11-03B. Riley SecuritiesDowngrade Buy -> Neutral
2022-11-03Northland Capital MarketsDowngrade Outperform -> Market Perform
2022-10-04B. Riley SecuritiesMaintains Buy
2022-06-15B. Riley SecuritiesMaintains Buy
2022-04-25Craig-HallumInitiate Buy
2022-04-14B. Riley SecuritiesMaintains Buy
2021-04-13B. Riley FBRInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.16
Revenue Estimate
7.055M
Revenue Q2Q
33.90%
EPS Q2Q
25.53%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
10.71%

Next Earnings Summary

INVE is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is -0.16 USD and the consensus revenue estimate is 7.05M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
INVE revenue by date.INVE revenue by date.
43.445M
-61.52%
26.628M
-38.71%
21.484M
-19.32%
25.585M
19.09%
30.804M
20.40%
142.9M
363.90%
EBITDA
YoY % growth
INVE ebitda by date.INVE ebitda by date.
-10.616M
-589.22%
-24.551M
-131.26%
N/A
42.67%
-11.295M
19.75%
19.584M
273.39%
21.93M
11.98%
EBIT
YoY % growth
INVE ebit by date.INVE ebit by date.
-13.348M
-13,248.00%
-27.421M
-105.43%
-20.622M
24.79%
-22.102M
-7.18%
-17.43M
21.14%
N/A
Operating Margin
INVE operating margin by date.INVE operating margin by date.
-30.72%-102.98%-95.99%-86.39%-56.58%N/A
EPS
YoY % growth
INVE eps by date.INVE eps by date.
-0.28
-300.00%
-1.06
-278.57%
-0.78
26.42%
-0.69
11.08%
N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.16
25.53%
-0.16
38.54%
-0.16
-8.80%
-0.17
-4.12%
-0.15
2.17%
-0.14
10.64%
-0.14
12.50%
-0.13
20.41%
Revenue
Q2Q % growth
7.055M
33.90%
6.188M
22.78%
6.222M
24.22%
6.766M
9.73%
7.14M
1.20%
7.65M
23.63%
8.364M
34.43%
9.282M
37.19%
EBITDA
Q2Q % growth
-2.636M
44.12%
-2.818M
43.50%
-2.877M
21.55%
-2.966M
17.00%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-4.414M
15.25%
-4.519M
24.27%
-4.492M
13.28%
-4.465M
-4.63%
N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

INVE Yearly Revenue VS EstimatesINVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M
INVE Yearly EPS VS EstimatesINVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
88.38%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
43.17%
EBIT Next 5 Year
N/A

IDENTIV INC / INVE Forecast FAQ

What do analysts expect the price target to be for IDENTIV INC (INVE)?

9 analysts have analysed INVE and the average price target is 5.44 USD. This implies a price increase of 48.23% is expected in the next year compared to the current price of 3.67.

When does IDENTIV INC (INVE) report earnings?

IDENTIV INC (INVE) will report earnings on 2026-05-05.

Can you provide the consensus estimates for IDENTIV INC next earnings?

The consensus EPS estimate for the next earnings of IDENTIV INC (INVE) is -0.16 USD and the consensus revenue estimate is 7.05M USD.

Can you provide the consensus rating for IDENTIV INC stock?

The consensus rating for IDENTIV INC (INVE) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.